Latest Cardiac surgery Stories
More Patients Now Will Be Eligible for TAVR Procedure. CLEARWATER, Fla., Oct. 19, 2012 /PRNewswire-USNewswire/ -- Morton Plant Hospital is the first hospital in the Tampa Bay area to perform Transcatheter Aortic Valve Replacement (TAVR) by the transapical approach. Transapical TAVR is the latest FDA-approved treatment for people suffering from severe aortic stenosis. Aortic stenosis is a narrowing of the aortic valve of the heart, which causes the valve to fail to open...
TUCSON, Ariz., Oct. 18, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that San Raffaele Hospital in Milan, Italy, has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. On Sept. 7, 55-year-old Marco Fumagalli left the hospital to wait for a matching donor heart at home using the Freedom® portable...
--Neovasc's Tiara(TM) Transcatheter Mitral Valve Selected for Inclusion in "Best" New Device Concepts for 2012 Session-- --Other Presentations Include Tiara Project Update and Neovasc Reducer(TM) Preliminary Registry Results-- TSX Venture Exchange: NVC VANCOUVER, Oct. 18, 2012 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that researchers will present data on the company's two major development products at the upcoming 24(th) Annual Transcatheter Cardiovascular...
NATICK, Mass., Oct. 10, 2012 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus(TM) Valve System in up to 120 patients with severe aortic valve disease. This international, multi-center study includes 15 sites in Australia, France, Germany and the United Kingdom. The Lotus Valve System is the first transcatheter aortic valve replacement (TAVR) device of its kind that is...
MESA, Ariz., Oct. 4, 2012 /PRNewswire/ -- Banner Heart Hospital has been named one of the nation's 50 Top Cardiovascular Hospitals by Truven Health Analytics, formerly the health care business of Thomson Reuters. The study examined the performance of more than 1,000 hospitals by analyzing outcomes for patients with heart failure and heart attacks and for those who received coronary bypass surgery and percutaneous coronary interventions such as angioplasties. This is the fourth...
Prosthetics can be enlarged as children grow, reducing need for future replacement surgeries BOSTON, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Surgeons at Boston Children's Hospital have successfully implanted a modified version of an expandable prosthetic heart valve in several children with mitral valve disease. Unlike traditional prosthetic valves that have a fixed diameter, the expandable valve can be enlarged as a child grows, thus potentially avoiding the repeat valve...
Study is only one of its kind to evaluate minimally invasive valve surgery approach in patients with chronic obstructive pulmonary disease MIAMI BEACH, Fla., Oct. 2, 2012 /PRNewswire-USNewswire/ -- The European Journal of Cardio-Thoracic Surgery has published a first of its kind study conducted at Mount Sinai Medical Center of Florida reporting the outcomes of minimally invasive valve surgery versus traditional median sternotomy in patients with chronic obstructive pulmonary disease...
WAYNE, N.J., Oct. 1, 2012 /PRNewswire/ -- MAQUET Medical Systems USA, a leader in extracorporeal life support (ECLS) systems, today announced that its CARDIOHELP System has been used successfully in 100 cases in patients whose heart and/or lungs are failing since the System was launched in the United States last year. "The completion of the 100th case using CARDIOHELP in the United States is a testament to the extreme versatility of the device and its remarkable ability to provide...
KIRKLAND, Wash., Sept. 28, 2012 /PRNewswire/ --Cardiac Dimensions(®),( )Inc. today announced that it has initiated its commercial efforts in Europe, treating the first patients with its CARILLON® Mitral Contour System® under its Conformite Europeenne (CE) Mark approval. The CARILLON system is a novel, minimally invasive therapy for treating heart patients suffering from functional mitral regurgitation (FMR). An estimated 70 percent of the 20 million people worldwide with heart...
Breakthrough heart-assist technique, led by Cardiovascular Institute heart specialist Dr. Theodore Schreiber, underlines DMC role as national innovator in cardiac care; patient "comfortable and already back at work" one day after painless, 60-minute procedure Physicians and patient are available for interviews DETROIT, Sept. 26, 2012 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) announced today that the hospital group's Cardiovascular Institute (CVI) has conducted the...
Latest Cardiac surgery Reference Libraries
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...
